Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy. [electronic resource]
Producer: 19940601Description: 2359-65 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Carcinoma, Ductal, Breast -- drug therapy
- Cell Membrane -- ultrastructure
- Chemotherapy, Adjuvant
- Cytoplasm -- ultrastructure
- Female
- Flow Cytometry
- Follow-Up Studies
- Gene Expression Regulation, Neoplastic
- Humans
- Immunoenzyme Techniques
- Lymphatic Metastasis -- pathology
- Middle Aged
- Oncogene Proteins, Viral -- genetics
- Prognosis
- Receptor, ErbB-2
- Survival Rate
- Tamoxifen -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.